These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 909069)

  • 1. First-pass effect of nalorphine in rats.
    Iwamoto K; Klaassen CD
    J Pharmacol Exp Ther; 1977 Nov; 203(2):365-76. PubMed ID: 909069
    [No Abstract]   [Full Text] [Related]  

  • 2. First-pass effect of morphine in rats.
    Iwamoto K; Klaassen CD
    J Pharmacol Exp Ther; 1977 Jan; 200(1):236-44. PubMed ID: 833759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of morphine and nalorphine by isolated rat hepatocytes.
    Iwamoto K; Eaton DL; Klaassen CD
    J Pharmacol Exp Ther; 1978 Jul; 206(1):181-9. PubMed ID: 660548
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of nalorphine on the in vitro morphine metabolism and on the p-nitrophenol conjugation in rat liver.
    Tampier L; Sanchez E; Mardones J
    Arch Int Pharmacodyn Ther; 1970 Dec; 188(2):290-7. PubMed ID: 5523475
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect.
    Kang HE; Cho YK; Jung HY; Choi KY; Sohn SI; Baek SR; Lee MG
    Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro model for studying effects of morphine and nalorphine on 45 Ca-ganglioside binding.
    Greenberg S; Diecke FP; Long JP
    J Pharm Sci; 1972 Sep; 61(9):1471-3. PubMed ID: 5068955
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine metabolism. II. Studies on morphine glucuronyltransferase activity in intestinal microsomes of rats.
    Del Villar E; Sanchez E; Tephly TR
    Drug Metab Dispos; 1974; 2(4):370-4. PubMed ID: 4153409
    [No Abstract]   [Full Text] [Related]  

  • 10. Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.
    Nishimura T; Amano N; Kubo Y; Ono M; Kato Y; Fujita H; Kimura Y; Tsuji A
    Drug Metab Dispos; 2007 Aug; 35(8):1275-84. PubMed ID: 17470527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
    Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H
    Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Dealkylation of morphine and nalorphine in the brain of living rats.
    MILTHERS K
    Nature; 1962 Aug; 195():607. PubMed ID: 14474244
    [No Abstract]   [Full Text] [Related]  

  • 13. Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.
    Klippert PJ; Hulshoff A; Mingels MJ; Hofman G; Noordhoek J
    Cancer Res; 1983 Jul; 43(7):3160-4. PubMed ID: 6406053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidance of "first-pass" elimination of rectally administered lidocaine in relation to the site of absorption in rats.
    de Leede LG; de Boer AG; Roozen CP; Breimer DD
    J Pharmacol Exp Ther; 1983 Apr; 225(1):181-5. PubMed ID: 6834271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative distribution of morphine and nalorphine in dog brain.
    WOODS LA
    J Pharmacol Exp Ther; 1957 May; 120(1):58-62. PubMed ID: 13449703
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat.
    Knodell RG; Spector MH; Brooks DA; Keller FX; Kyner WT
    Gastroenterology; 1980 Dec; 79(6):1211-6. PubMed ID: 6777235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.